AI assistant
Sending…
APPLIED DNA SCIENCES INC — Director's Dealing 2026
Feb 13, 2026
35347_dirs_2026-02-13_5bdf963f-d036-4e24-8803-ec45f20da36a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BNB PLUS CORP. (BNBX)
CIK: 0000744452
Period of Report: 2026-02-02
Reporting Person: Haft James (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-02 | Incentive Stock Option (right to buy) | $1.31 | A | 80730 | Acquired | 2036-02-02 | Common Stock (80730) | Direct |
| 2026-02-02 | Non-Qualified Stock Option (right to buy) | $1.31 | A | 12270 | Acquired | 2036-02-02 | Common Stock (12270) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 22590 | Direct |
Footnotes
F1: The options vest in four equal installments on May 2, 2026, August 2, 2026, November 2, 2026 and February 2, 2027.
More from APPLIED DNA SCIENCES INC
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 24
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 12
Major Shareholding Notification
2026
Feb 13
Interim / Quarterly Report
2026
Feb 12
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Jan 30